BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hazari YM, Bashir A, Habib M, Bashir S, Habib H, Qasim MA, Shah NN, Haq E, Teckman J, Fazili KM. Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions. Mutat Res. 2017;773:14-25. [PMID: 28927525 DOI: 10.1016/j.mrrev.2017.03.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Regan KH, Hill AT. Emerging therapies in adult and paediatric bronchiectasis. Respirology 2018;23:1127-37. [DOI: 10.1111/resp.13407] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
2 Bai X, Hippensteel J, Leavitt A, Maloney JP, Beckham D, Garcia C, Li Q, Freed BM, Ordway D, Sandhaus RA, Chan ED. Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19. Med Hypotheses 2021;146:110394. [PMID: 33239231 DOI: 10.1016/j.mehy.2020.110394] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
3 Haugabook SJ, Ferrer M, Ottinger EA. In vitro and in vivo translational models for rare liver diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019;1865:1003-18. [DOI: 10.1016/j.bbadis.2018.07.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
4 Zhang X, Pham K, Li D, Schutte RJ, Brantly M, Liu C, Ostrov DA. Targeting the site encoded by SERPINA1*E342K for treating alpha-1 antitrypsin deficiency-associated liver diseases. FEBS Lett 2019;593:1849-62. [PMID: 31116417 DOI: 10.1002/1873-3468.13452] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Böer-Auer A, Fölster-Holst R. [Skin biopsy of inflammatory skin diseases in childhood-when is it reasonable?]. Hautarzt 2018;69:536-49. [PMID: 29869129 DOI: 10.1007/s00105-018-4205-7] [Reference Citation Analysis]
6 Kouroumalis E, Voumvouraki A, Augoustaki A, Samonakis DN. Autophagy in liver diseases. World J Hepatol 2021; 13(1): 6-65 [PMID: 33584986 DOI: 10.4254/wjh.v13.i1.6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
7 Kim SH, Ahn HS, Park JS, Yeom J, Yu J, Kim K, Oh YM. A Proteomics-Based Analysis of Blood Biomarkers for the Diagnosis of COPD Acute Exacerbation. Int J Chron Obstruct Pulmon Dis 2021;16:1497-508. [PMID: 34113087 DOI: 10.2147/COPD.S308305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Gough A, Soto-Gutierrez A, Vernetti L, Ebrahimkhani MR, Stern AM, Taylor DL. Human biomimetic liver microphysiology systems in drug development and precision medicine. Nat Rev Gastroenterol Hepatol 2021;18:252-68. [PMID: 33335282 DOI: 10.1038/s41575-020-00386-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
9 Buendia-Roldan I, Palma-Lopez A, Chan-Padilla D, Herrera I, Maldonado M, Fernández R, Martínez-Briseño D, Mejia M, Selman M. Risk factors associated with the detection of pulmonary emphysema in older asymptomatic respiratory subjects. BMC Pulm Med 2020;20:164. [PMID: 32517728 DOI: 10.1186/s12890-020-01204-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Emwas AH, Alghrably M, Dhahri M, Sharfalddin A, Alsiary R, Jaremko M, Faa G, Campagna M, Congiu T, Piras M, Piludu M, Pichiri G, Coni P, Lachowicz JI. Living with the enemy: from protein-misfolding pathologies we know, to those we want to know. Ageing Res Rev 2021;70:101391. [PMID: 34119687 DOI: 10.1016/j.arr.2021.101391] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Baldanzi G, Malerba M. DGKα in Neutrophil Biology and Its Implications for Respiratory Diseases. Int J Mol Sci 2019;20:E5673. [PMID: 31766109 DOI: 10.3390/ijms20225673] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhang L, Valizadeh H, Alipourfard I, Bidares R, Aghebati-Maleki L, Ahmadi M. Epigenetic Modifications and Therapy in Chronic Obstructive Pulmonary Disease (COPD): An Update Review. COPD 2020;17:333-42. [PMID: 32558592 DOI: 10.1080/15412555.2020.1780576] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Ahmed CMS, Cui Y, Frie AL, Burr A, Kamath R, Chen JY, Rahman A, Nordgren TM, Lin YH, Bahreini R. Exposure to Dimethyl Selenide (DMSe)-Derived Secondary Organic Aerosol Alters Transcriptomic Profiles in Human Airway Epithelial Cells. Environ Sci Technol 2019;53:14660-9. [PMID: 31751125 DOI: 10.1021/acs.est.9b04376] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
14 Hazari Y, Bravo-San Pedro JM, Hetz C, Galluzzi L, Kroemer G. Autophagy in hepatic adaptation to stress. J Hepatol. 2020;72:183-196. [PMID: 31849347 DOI: 10.1016/j.jhep.2019.08.026] [Cited by in Crossref: 47] [Cited by in F6Publishing: 54] [Article Influence: 47.0] [Reference Citation Analysis]
15 Beckmeyer-Borowko A, Imboden M, Rezwan FI, Wielscher M, Amaral AFS, Jeong A, Schaffner E, Auvinen J, Sebert S, Karhunen V, Bettschart R, Turk A, Pons M, Stolz D, Kronenberg F, Arathimos R, Sharp GC, Relton C, Henderson AJ, Jarvelin MR, Jarvis D, Holloway JW, Probst-Hensch NM. SERPINA1 methylation and lung function in tobacco-smoke exposed European children and adults: a meta-analysis of ALEC population-based cohorts. Respir Res 2018;19:156. [PMID: 30134983 DOI: 10.1186/s12931-018-0850-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
16 Malintan NT, Buckingham SD, Lomas DA, Sattelle DB. Calcium signalling in mammalian cell lines expressing wild type and mutant human α1-Antitrypsin. Sci Rep 2019;9:17293. [PMID: 31754242 DOI: 10.1038/s41598-019-53535-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Viglio S, Bak EG, Schouten IGM, Iadarola P, Stolk J. Protease-Specific Biomarkers to Analyse Protease Inhibitors for Emphysema Associated with Alpha 1-Antitrypsin Deficiency. An Overview of Current Approaches. Int J Mol Sci 2021;22:1065. [PMID: 33494436 DOI: 10.3390/ijms22031065] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Giacopuzzi E, Laffranchi M, Berardelli R, Ravasio V, Ferrarotti I, Gooptu B, Borsani G, Fra A. Real-world clinical applicability of pathogenicity predictors assessed on SERPINA1 mutations in alpha-1-antitrypsin deficiency. Human Mutation 2018;39:1203-13. [DOI: 10.1002/humu.23562] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
19 Vidova V, Stuchlikova E, Vrbova M, Almasi M, Klanova J, Thon V, Spacil Z. Multiplex Assay for Quantification of Acute Phase Proteins and Immunoglobulin A in Dried Blood Spots. J Proteome Res 2019;18:380-91. [PMID: 30408962 DOI: 10.1021/acs.jproteome.8b00657] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Raissi D, Yu Q, Nisiewicz M, Krohmer S. Parallel transjugular intrahepatic portosystemic shunt with Viatorr® stents for primary TIPS insufficiency: Case series and review of literature . World J Hepatol 2019; 11(2): 217-225 [PMID: 30820271 DOI: 10.4254/wjh.v11.i2.217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Bashir A, Hazari Y, Pal D, Maity D, Bashir S, Singh LR, Shah NN, Fazili KM. Aggregation of M3 (E376D) variant of alpha1- antitrypsin. Sci Rep 2020;10:8290. [PMID: 32427833 DOI: 10.1038/s41598-020-64860-1] [Reference Citation Analysis]
22 Rashed WM, Kandeil MAM, Mahmoud MO, Ezzat S. Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview. J Egypt Natl Canc Inst 2020;32:5. [PMID: 32372179 DOI: 10.1186/s43046-020-0016-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 13.0] [Reference Citation Analysis]
23 Bashir A, Hazari YM, Bashir S, Hilal N, Banday M, Iqbal MK, Jan TR, Farooq SS, Shah NN, Fazili KM. SERPINA1 Hepatocyte-Specific Promoter Polymorphism Associate with Chronic Obstructive Pulmonary Disease in a Study of Kashmiri Ancestry Individuals. Lung 2018;196:447-54. [PMID: 29804144 DOI: 10.1007/s00408-018-0124-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Purghè B, Manfredi M, Ragnoli B, Baldanzi G, Malerba M. Exosomes in chronic respiratory diseases. Biomed Pharmacother 2021;144:112270. [PMID: 34678722 DOI: 10.1016/j.biopha.2021.112270] [Reference Citation Analysis]
25 Lior Y, Jasevitch M, Ochayon DE, Zaretsky M, Lewis EC, Aharoni A. Application of directed evolution and back-to-consensus algorithms to human alpha1-antitrypsin leads to diminished anti-protease activity and augmented anti-inflammatory activities. Cell Immunol 2020;355:104135. [PMID: 32703529 DOI: 10.1016/j.cellimm.2020.104135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Skerrett-Byrne DA, Bromfield EG, Murray HC, Jamaluddin MFB, Jarnicki AG, Fricker M, Essilfie AT, Jones B, Haw TJ, Hampsey D, Anderson AL, Nixon B, Scott RJ, Wark PAB, Dun MD, Hansbro PM. Time-resolved proteomic profiling of cigarette smoke-induced experimental chronic obstructive pulmonary disease. Respirology 2021. [PMID: 34224176 DOI: 10.1111/resp.14111] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Johnson EF, Tolkachjov SN, Gibson LE. Alpha-1 antitrypsin deficiency panniculitis: clinical and pathologic characteristics of 10 cases. Int J Dermatol 2018;57:952-8. [DOI: 10.1111/ijd.14012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
28 Potilinski MC, Ortíz GA, Salica JP, López ES, Fernández Acquier M, Chuluyan E, Gallo JE. Elucidating the mechanism of action of alpha-1-antitrypsin using retinal pigment epithelium cells exposed to high glucose. Potential use in diabetic retinopathy. PLoS One 2020;15:e0228895. [PMID: 32032388 DOI: 10.1371/journal.pone.0228895] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
29 Scott BM, Sheffield WP. Engineering the serpin α1 -antitrypsin: A diversity of goals and techniques. Protein Sci 2020;29:856-71. [PMID: 31774589 DOI: 10.1002/pro.3794] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
30 Potilinski MC, Lorenc V, Perisset S, Gallo JE. Mechanisms behind Retinal Ganglion Cell Loss in Diabetes and Therapeutic Approach. Int J Mol Sci 2020;21:E2351. [PMID: 32231131 DOI: 10.3390/ijms21072351] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]